Theravance Biopharma logo
Theravance Biopharma
TBPH | NASDAQ
Chart Builder DCF Calculator
$17.03
$0.00 (0.00%)
At close: Sep 23, 2026, 4:00 PM ET

Theravance Biopharma Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-5.9M -4.93M 61.02M 3.62M 54.84M -13.58M -15.53M -12.7M -16.53M -11.66M -8.51M -8.95M -15.65M -22.09M -14.26M -15.52M -22.79M -40.26M -32.03M -75.17M -52.41M -79.68M
2.05M 835K 430K 636K 927K 1.05M 695K 762K 979K 1.18M 1.42M 937K 924K 978K 2.03M 1.77M 1.91M 1.32M 2.39M 2.61M 2.42M 2.29M
5.99M 4.5M 4.48M 4.58M 4.54M 4.88M 5.83M 4.96M 5.38M 5.23M 5.82M 6.26M 6.26M 7.02M 6.95M 8.53M 9.71M 14.55M 16.92M 14.37M 14.94M 15.83M
2.66M -2.66M 162.46M -21.07M 165.1M -1.32M 14.69M 2.42M 2.33M 1.12M -2.65M -355K -1.43M -3.23M 65.99M -15.78M 589K -4.12M -1.71M -4.11M -17.88M -15.99M
66.95M 42K -333.7M 551K 664K 604K 806K 2.03M 3.63M 629K 3.83M 610K 1.89M 579K -178.33M -1.69M -5.53M 2.27M -22.19M 20.46M -1.98M 4.8M
-218K -3M 30K 994K -10.69M -1.85M -6.59M 90K -561K -513K – – – – – – – – – – – –
-77.75M 75.83M 261.67M -16.88M 157.8M 51.94M 13.89M -342K 2.69M 4.12M -3.41M -1.35M -5.87M 2.29M 59.56M -15.23M 1.97M -3.95M -7.52M -7.71M -13.09M -13.11M
-8.88M 73.28M -6.06M -6.51M 208.07M 43.04M -902K -5.2M -4.42M -1.02M -854K -2.49M -12.44M -11.22M -124.06M -22.14M -14.73M -26.07M -42.43M -45.45M -50.11M -69.87M
– – -8K – -34K – -190K -15K -36K -91K -677K -21K -852K -938K -266K 57K -113K -250K -444K -1.04M -156K -1.77M
– – – – – – – – – – – – – – – – – – – – – –
-101.9M -43.41M -64.93M -124.75M -56.57M -1.97M -40.01M -44.88M -31.24M -26.9M – – -1K -134.53M -9.89M -39.5M -35.59M -18.17M -53.53M -64.76M -39.98M -36K
41.5M 96M 65.53M 24.5M 20.35M 32.6M 55.89M 27.5M 28.24M 44.02M – – 10.6M 92.22M 49.31M 17.01M 43.2M 48.5M 64.8M 30M 75.9M 115.5M
– – – – – – – – – – – – 1.3M 210K – 1.1B 17K 1.85M – 6K – –
-60.4M 52.59M 588K -100.25M -36.26M 30.63M 15.69M -17.4M -3.03M 17.03M -677K -21K 11.05M -43.05M 39.16M 1.08B 7.52M 31.92M 10.82M -35.79M 35.77M 113.7M
– – – – – – – – – – – – – – – -631.6M – – – – -5.03M -5.7M
5.82M -5.82M -1.98M -678K -503K -874K -528K -397K -463K -1.72M -30.78M -31.4M -81.13M -56.24M -35.79M -94.7M -347K -1.45M -455K -2.29M -727K -5.59M
– – – – – – – – – – – – – – – – – – – – – –
-967K – – – – – 133K – 375K – 173K -1K 446K – 314K 4.28M 487K – 604K – 2.86M 3K
4.61M -5.58M -1.49M -400K -503K -854K -365K -372K -44K -1.72M -30.61M -31.4M -80.68M -56.24M -35.47M -722.03M 140K -1.45M 149K -2.29M 105.29M -11.29M
-64.67M 120.3M -6.97M -107.15M 171.31M 72.82M 14.42M -22.97M -7.49M 14.29M -32.14M -33.91M -82.07M -110.51M -120.37M 331.25M -7.08M 4.41M -31.46M -83.53M 90.94M 32.54M
-8.88M 73.28M -6.07M -6.51M 208.04M 43.04M -1.09M -5.21M -4.45M -1.11M -1.53M -2.51M -13.29M -12.16M -124.32M -22.08M -14.84M -26.32M -42.88M -46.49M -50.27M -71.63M
-14.87M 68.78M -10.55M -11.08M 203.5M 38.16M -6.92M -10.17M -9.83M -6.34M -7.36M -8.77M -19.55M -19.18M -131.27M -30.61M -24.55M -40.86M -59.8M -60.86M -65.21M -87.46M
– – – – – – – – – – – – – -938K -266K 57K -113K -250K -444K -1.04M -156K -1.77M
– – -8K – -34K – -190K -15K -36K -91K -677K -21K -852K – – – – – – – – –
-8.88M 73.28M -6.06M -6.51M 208.07M 43.04M -902K -5.2M -4.42M -1.02M -854K -2.49M -12.44M -12.16M -124.32M -22.08M -14.84M -26.32M -42.88M -46.49M -50.27M -71.63M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.